Sofinnova Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-176,181
| Closed | -$47.6M | – | 57 |
|
|
2025
Q1 | $47.6M | Buy |
176,181
+66,024
| +60% | +$17.8M | 3.11% | 6 |
|
|
2024
Q4 | $25.9M | Buy |
+110,157
| New | +$25.9M | 1.89% | 17 |
|
|
2024
Q3 | – | Sell |
-147,929
| Closed | -$35.9M | – | 60 |
|
|
2024
Q2 | $35.9M | Buy |
147,929
+44,893
| +44% | +$10.9M | 1.87% | 15 |
|
|
2024
Q1 | $15.4M | Buy |
+103,036
| New | +$15.4M | 0.86% | 30 |
|
|
2023
Q2 | – | Sell |
-448
| Closed | -$89.7K | – | 49 |
|
|
2023
Q1 | $89.7K | Sell |
448
-56,000
| -99% | -$11.2M | 0.01% | 49 |
|
|
2022
Q4 | $13.4M | Buy |
+56,448
| New | +$13.4M | 0.8% | 27 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 64 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 69 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 59 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 59 |
|
|
2019
Q3 | – | Sell |
-27,792
| Closed | -$2.02M | – | 69 |
|
|
2019
Q2 | $2.02M | Sell |
27,792
-78,824
| -74% | -$5.72M | 0.19% | 51 |
|
|
2019
Q1 | $9.96M | Buy |
+106,616
| New | +$9.96M | 0.96% | 19 |
|